Surgisphere

Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai. The company came under scrutiny after it had provided large datasets of COVID-19 patients that were subsequently found to be unreliable. The data was used in studies that were published in the The Lancet and The New England Journal of Medicine in May 2020. The studies suggested that patients on hydroxychloroquine had “significantly higher risks of death“. In light of these studies, the World Health Organization decided to halt global trials of the drug hydroxychloroquine to treat COVID-19 in order to focus on patented drugs. After the studies were retracted, the WHO trials were resumed.